TriFlo Cardiovascular, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.triflocv.com
Transcatheter Treatment of Tricuspid Valve Regurgitation
Not Applicable
Not yet recruiting
- Conditions
- Symptomatic Severe Tricuspid Regurgitation
- Interventions
- Device: TriFlo Tricuspid Flow Optimizer
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- TriFlo Cardiovascular, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06093828
- Locations
- 🇮🇹
IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
🇮🇹Pineta Grande Hospital, Castel Volturno, Caserta, Italy
🇮🇹IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy
© Copyright 2025. All Rights Reserved by MedPath